E01H0029 Human Hyaluronic Acid ELISA kit
The Human Hyaluronic Acid ELISA kit can be used to identify samples from the human species. Hyaluronic Acid can also be called HA, hyaluronan, Hyaluronan, Hyaluronate.
E01H0029 Human Hyaluronic Acid ELISA kit
The Human Hyaluronic Acid ELISA kit can be used to identify samples from the human species. Hyaluronic Acid can also be called HA, hyaluronan, Hyaluronan, Hyaluronate.
Product Information | |
Cat. No. | E01H0029 |
Product Name | Human Hyaluronic Acid ELISA kit |
Species | Human |
Product Size | 48 Tests / 96 Tests |
Concentration | 25-500 ng/ml |
Sensitivity | 1.0 ng/ml |
Principal | Competitive ELISA |
Sample Volume | 100 ul |
Sample Type | Serum, plasma, cell culture supernatants, body fluid and tissue homogenate |
Assay Time | 90 minutes |
Platform | Microplate Reader |
Conjugate | HRP |
Detection Method | Colorimetric |
Storage | 2-8°C |
Kit Components | ||
MATERIALS | SPECIFICATION | QUANTITY |
MICROTITER PLATE | 96 wells | stripwell |
ENZYME CONJUGATE | 6.0 mL | 1 vial |
STANDARD A (0.5mL) | 0 ng/mL | 1 vial |
STANDARD B (0.5mL) | 25 ng/mL | 1 vial |
STANDARD C (0.5mL) | 50 ng/mL | 1 vial |
STANDARD D (0.5mL) | 100 ng/mL | 1 vial |
STANDARD E (0.5mL) | 250 ng/mL | 1 vial |
STANDARD F (0.5mL) | 500 ng/mL | 1 vial |
SUBSTRATE A | 6 mL | 1 vial |
SUBSTRATE B | 6 mL | 1 vial |
STOP SOLUTION | 6 mL | 1 vial |
WASH SOLUTION (100 x) | 10 mL | 1 vial |
BALANCE SOLUTION | 3 mL | 1 vial |
Principle of the Assay |
HA ELISA kit uses an anti-HA antibody and an HA-HRP conjugate in a competitive enzyme immunoassay method. HA-HRP conjugate is incubated with the assay sample and buffer in a pre-coated plate for one hour. The wells are decanted and washed five times when the incubation period is over. The HRP enzyme substrate is then incubated in the wells. The result of the enzyme-substrate reaction is a complex that is blue in hue. The process is finally stopped by adding a stop solution, causing the solution to turn yellow. In a microplate reader, the color intensity is measured spectrophotometrically at 450 nm. Due to competition for the anti-HA antibody binding site between HA from samples and HA-HRP conjugate, the intensity of the color is inversely proportional to the concentration of HA. Since the number of sites is limited, as more sites are occupied by HA from the sample, fewer sites are left to bind HA-HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The HA concentration in each sample is interpolated from this standard curve. |
Coefficient of Variance | Intra Variation% <10% | |
Inter Variation% <12% | ||
Recovery | 95-102% | |
Linearity | Diluent Ratio | Range % |
1:2 | 93-105 | |
1:4 | 88-106 | |
1:8 | 86-108 | |
Specificity/Cross-reactivity | No significant cross-reactivity or interference between HA and analogues was observed. |
E01H0029 has been referenced in the below publications:
Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.
Flavonoid-rich Scabiosa comosa inflorescence extract attenuates CCl4-induced hepatic fibrosis by modulating TGF-β-induced Smad3 phosphorylation.
Effects of Complementary Combination Therapy of Korean Red Ginseng and Antiviral Agents in Chronic Hepatitis B.
Cartilage metabolic markers and antioxidants: its correlation in osteoarthritic patients of sikkim.
Related Bluegene Biotech Products
BlueGene Biotech News